223 related articles for article (PubMed ID: 32200201)
1. In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBP.
Kang D; Feng D; Jing L; Sun Y; Wei F; Jiang X; Wu G; De Clercq E; Pannecouque C; Zhan P; Liu X
Eur J Med Chem; 2020 May; 193():112237. PubMed ID: 32200201
[TBL] [Abstract][Full Text] [Related]
2. Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus.
Zhou Z; Liu T; Wu G; Kang D; Fu Z; Wang Z; De Clercq E; Pannecouque C; Zhan P; Liu X
Org Biomol Chem; 2019 Mar; 17(12):3202-3217. PubMed ID: 30839042
[TBL] [Abstract][Full Text] [Related]
3. In situ click chemistry-based discovery of 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs by exploiting the tolerant region I in binding pocket.
Sun Y; Feng D; Zhou Z; Zhang T; De Clercq E; Pannecouque C; Kang D; Zhan P; Liu X
Bioorg Med Chem; 2023 Dec; 96():117484. PubMed ID: 37976805
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored "hydrophobic channel".
Zhou Z; Liu T; Kang D; Huo Z; Wu G; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
Org Biomol Chem; 2018 Feb; 16(6):1014-1028. PubMed ID: 29349445
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket.
Meng Q; Chen X; Kang D; Huang B; Li W; Zhan P; Daelemans D; De Clercq E; Pannecouque C; Liu X
Eur J Med Chem; 2016 Jun; 115():53-62. PubMed ID: 26994843
[TBL] [Abstract][Full Text] [Related]
6. Application of the Huisgen cycloaddition and 'click' reaction toward various 1,2,3-triazoles as HIV non-nucleoside reverse transcriptase inhibitors.
Pribut N; Veale CG; Basson AE; van Otterlo WA; Pelly SC
Bioorg Med Chem Lett; 2016 Aug; 26(15):3700-4. PubMed ID: 27287366
[TBL] [Abstract][Full Text] [Related]
7. Exploiting the hydrophobic channel of the NNIBP: Discovery of novel diarylpyrimidines as HIV-1 NNRTIs against wild-type and K103N mutant viruses.
Fu Z; Zhang T; Zhou Z; Kang D; Sun L; Gao S; Cherukupalli S; De Clercq E; Pannecouque C; Liu X; Zhan P
Bioorg Med Chem; 2021 Jul; 42():116239. PubMed ID: 34090079
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
Yang J; Chen W; Kang D; Lu X; Li X; Liu Z; Huang B; Daelemans D; Pannecouque C; De Clercq E; Zhan P; Liu X
Eur J Med Chem; 2016 Feb; 109():294-304. PubMed ID: 26802545
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel potent HIV-1 inhibitors by exploiting the tolerant regions of the NNRTIs binding pocket.
Sun Y; Kang D; Da F; Zhang T; Li P; Zhang B; De Clercq E; Pannecouque C; Zhan P; Liu X
Eur J Med Chem; 2021 Mar; 214():113204. PubMed ID: 33567378
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays.
Chen W; Zhan P; Rai D; De Clercq E; Pannecouque C; Balzarini J; Zhou Z; Liu H; Liu X
Bioorg Med Chem; 2014 Mar; 22(6):1863-72. PubMed ID: 24581546
[TBL] [Abstract][Full Text] [Related]
11. Conformational restriction design of thiophene-biphenyl-DAPY HIV-1 non-nucleoside reverse transcriptase inhibitors.
Sang Y; Han S; Pannecouque C; De Clercq E; Zhuang C; Chen F
Eur J Med Chem; 2019 Nov; 182():111603. PubMed ID: 31421633
[TBL] [Abstract][Full Text] [Related]
12. Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.
Tian Y; Liu Z; Liu J; Huang B; Kang D; Zhang H; De Clercq E; Daelemans D; Pannecouque C; Lee KH; Chen CH; Zhan P; Liu X
Eur J Med Chem; 2018 May; 151():339-350. PubMed ID: 29635166
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs.
Wang Z; Yu Z; Kang D; Zhang J; Tian Y; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
Bioorg Med Chem; 2019 Feb; 27(3):447-456. PubMed ID: 30606670
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and antiviral evaluation of novel piperidine-substituted arylpyrimidines as HIV-1 NNRTIs by exploring the hydrophobic channel of NNIBP.
Zhang T; Zhou Z; Zalloum WA; Wang Z; Fu Z; Cherukupalli S; Feng D; Sun Y; Gao S; De Clercq E; Pannecouque C; Kang D; Zhan P; Liu X
Bioorg Chem; 2021 Nov; 116():105353. PubMed ID: 34536931
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing.
Zhao T; Meng Q; Kang D; Ji J; De Clercq E; Pannecouque C; Liu X; Zhan P
Eur J Med Chem; 2019 Nov; 182():111619. PubMed ID: 31434039
[TBL] [Abstract][Full Text] [Related]
16. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel DAPY-IAS hybrid derivatives as potential HIV-1 inhibitors using molecular hybridization based on crystallographic overlays.
Huang B; Wang X; Liu X; Chen Z; Li W; Sun S; Liu H; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
Bioorg Med Chem; 2017 Aug; 25(16):4397-4406. PubMed ID: 28659246
[TBL] [Abstract][Full Text] [Related]
18. Application of Structure-based Methods to Analyze Resistance Mutations for Chemically Diverse Non-Nucleoside Reverse Transcriptase Inhibitors.
Tabassum T; Azeem SM; Muwonge AN; Frey KM
Curr HIV Res; 2020; 18(4):283-291. PubMed ID: 32493197
[TBL] [Abstract][Full Text] [Related]
19. Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channel.
Jin X; Piao HR; Pannecouque C; De Clercq E; Zhuang C; Chen FE
Eur J Med Chem; 2021 Dec; 226():113868. PubMed ID: 34583311
[TBL] [Abstract][Full Text] [Related]
20. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F
Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
